Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cellular macromolecules refer to the broad class of essential biological polymers within bacterial cells, including DNA, RNA, proteins, and peptidoglycan, which serve as the fundamental targets for antimicrobial therapy [1][2]. These macromolecules are critical for bacterial survival; for instance, peptidoglycan maintains cell wall integrity, while ribosomes are responsible for translating genetic information into functional proteins [2][3]. Antibiotics exert their therapeutic effects by binding to specific sites on these macromolecules to inhibit their function, leading to either the death of the bacteria (bactericidal) or the inhibition of its growth (bacteriostatic) [1][4]. Because this term encompasses a wide variety of distinct molecular structures across many different species, it is considered a general category rather than a specific, well-defined therapeutic target [2]. Targeting these components is the primary strategy for treating bacterial infections, although the clinical efficacy of such drugs is increasingly threatened by the evolution of bacterial resistance mechanisms [4][5]. Sources: [1] StatPearls, Antibiotics (https://www.ncbi.nlm.nih.gov/books/NBK535444/); [2] Nature Reviews Microbiology, Antibiotic targets (https://www.nature.com/articles/nrmicro1470); [3] Merck Manual, Overview of Antibacterial Drugs (https://www.merckmanuals.com/professional/infectious-diseases/antibiotics/overview-of-antibacterial-drugs); [4] PMC, Mechanisms of Bacterial Resistance (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378521/); [5] NIH, The Human Microbiome (https://www.nih.gov/news-events/news-releases/nih-human-microbiome-project-defines-normal-bacterial-makeup-body).
Inhibition of cell wall synthesis, inhibition of protein synthesis (30S or 50S ribosomal subunits), inhibition of nucleic acid synthesis (DNA gyrase or RNA polymerase), and disruption of cell membrane integrity.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cellular macromolecules.